Revenue
EPS
EBIT
Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: JPY
Unlock Free Earnings Estimates
Astellas Pharma: Recording of fair value fluctuations related to conditional consideration and differences between consolidated earnings forecasts for the fiscal year ending 2025/3 and actual values
Apr 25 02:30 ET
Astellas Pharma: Supplementary financial results for the fiscal year ending March 2025
Astellas Pharma: Financial results briefing materials for the fiscal year ending March 2025
Astellas Pharma: Summary of financial results for the fiscal year ending March 31, 2025 [IFRS] (consolidated)
Read more